ResMed | RMD - Le Bénéfice D'Exploitation





Le Bénéfice D'Exploitation Changement Date
Ansell USD 146.5M 87.85M 2025-12
Artivion USD 4.79M 6.85M 2025-12
AtriCure USD 526K 1.96M 2026-03
Baxter International USD 66M 280.2M 2026-03
Cochlear AUD 261.1M 135.55M 2025-12
Cooper Companies USD -31M 243.8M 2026-03
CSL USD 2.64B 1.97B 2025-12
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Fisher Paykel Healthcare NZD 298.2M 2.8M 2025-12
Globus Medical USD 164M 17.31M 2026-03
Haemonetics USD 67.4M 8.9M 2025-12
Idexx Laboratories USD 362.59M 46.98M 2026-03
Inogen USD -7.79M 728K 2024-09
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
Medtronic USD 2.09B 354M 2026-03
Philips EUR 302M 417M 2026-03
Ramsay Health Care AUD 541.1M 3.9M 2025-12
ResMed USD 505.67M 8.07M 2026-03
Sigma Healthcare AUD 809K 13.76M 2024-12
Sonic Healthcare AUD 435.76M 193.66M 2024-12
Steris USD 318.7M 40.7M 2026-03
Teleflex USD 37.03M 686K 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03